Rad AI raised its Series C funding to $68 million, with $8 million from top U.S. health systems.
Key Details
- 1Advocate Health, Memorial Hermann, Corewell Health, and Atlantic Health System invested a combined $8 million.
- 2The total fundraising for Rad AI's Series C is $68 million.
- 3Rad AI's solutions reportedly impact nearly half of all imaging volumes in the U.S.
- 4The company achieved 8,710% revenue growth from 2020-2023.
- 5Rad AI is valued at $525 million according to Pitchbook estimates.
- 6The investment aims to drive systemwide adoption of radiology AI and address clinical and operational pressures.
Why It Matters
Such large-scale investment by major health systems signals growing confidence in radiology-focused AI solutions and supports further innovation and adoption. This collaboration could accelerate AI integration across the imaging workflow, with potential improvements in patient care and operational efficiency.
Source
Radiology Business
Related News
•HealthExec
FDA Eases Path for AI in Clinical Decision Support and Healthcare Innovation
FDA publishes new guidance to promote innovation in general wellness and clinical decision support, impacting medical AI including radiology.
•Radiology Business
Patients Favor AI in Imaging Diagnostics, Hesitate on Triage Use
Survey finds most patients support AI in diagnostic imaging but are reluctant about its use in triage decisions.
•Radiology Business
FDA Clears Multi-Disease AI Screening Platform for CT Imaging
HeartLung Corporation's AI-CVD platform receives FDA clearance to detect multiple diseases from a single CT scan.